"We really need Canadians to get vaccinated as quickly as possible".
On Monday, NACI updated it's recommendations on the use of COVID-19 vaccines to say that an mRNA COVID-19 vaccine should be preferentially offered to individuals in the authorized age groups, unless an mRNA vaccine has been ruled out in specific cases.
But she said it would be a very different risk-benefit analysis for someone working in a manufacturing plant without personal protective equipment in a province where COVID-19 is spreading like wildfire.
"I hope, I expect that people will decide that it's the right choice for them", Shandro said.
He said the doses would arrive on Canadian soil by Wednesday morning.
To date, more than 13 million Canadians or 34 percent of the population has received at least one dose.
He states he disagrees with the assessment and worries it will worsen vaccine hesitancy.
"It pains me to say this but it's past time to take NACI's recommendations with a grain of salt", emergency physician Dr. Brian Goldman said on Twitter.
Conservative MPs said the government needs to fix the communications disaster NACI has become.
According to AHS, the global frequency of VITT has been estimated at approximately one case in 100,000-250,000 doses of vaccine.
The later two vaccines have been linked to extremely rare blood-clots that have only been reported in 7 Canadians compared to the 1.7 million doses administered in the country. But the syndrome is so new, there is still little known about what the real risk is, why it is happening and who might be most likely to develop clots.
So NACI is recommending the mRNA Pfizer and Moderna vaccines over AstraZeneca and the newly-approved Johnson & Johnson Janssen one-dose vaccine - the latter two of which are based on viral vector technology.
Canada's inoculation drive was slow to get started and has struggled with repeated delivery delays, but appears to be back on track with millions of doses expected over the coming months. It's Alberta's first death linked to the vaccine.
Canada's first shipment of 300,000 doses of J&J's vaccine are on hold pending a quality control check.